価格表

在庫・価格 : 2025年04月29日 23時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-IKB alpha, Mouse-Mono(6A920)
データシート※最新のデータシートでない場合があります
NB100-56507SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 mg ¥41,000
(未発注)
追加

在庫・価格 : 2025年04月29日 23時55分 現在

Anti-IKB alpha, Mouse-Mono(6A920)

  • 商品コード:NB100-56507SS
  • メーカー:NOV
  • 包装:0.025mg
  • 価格: ¥41,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Saccani S et al. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J. Exp. Med. 2004 Jul;200(1):107-13
Saccani S et al
2004/01/01
Applications: WB PubMed
2 Yang M et al. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J. Immunol. 2005 Sep;175(5):2814-24
Yang M et al
2005/01/01
Applications: WB PubMed
3 Goodkin ML et al. NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection. J. Virol. 2003 Jul;77(13):7261-80
Goodkin ML et al
2003/01/01
Applications: WB PubMed
4 Endo T et al. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 2007 Jan;109(2):703-10
Endo T et al
2007/01/01
Species: Human, Applications: WB PubMed
5 Ikezoe T et al. PC-SPES: a potent inhibitor of nuclear factor-kappa B rescues mice from lipopolysaccharide-induced septic shock. Mol. Pharmacol. 2003 Dec;64(6):1521-9
Ikezoe T et al
2003/01/01
Applications: WB PubMed
6 Vilimas T et al. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat. Med. 2007 Jan;13(1):70-7
Vilimas T et al
2007/01/01
Applications: WB, IP PubMed
7 Nishioka C et al. DHMEQ, a novel nuclear factor-kappaB inhibitor, induces selective depletion of alloreactive or phytohaemagglutinin-stimulated peripheral blood mononuclear cells, decreases production of T helper type 1 cytokines, and blocks maturation of
Nishioka C et al
2008/01/01
Applications: PubMed
8 Chang L et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006 Feb;124(3):601-13
Chang L et al
2006/01/01
Applications: WB PubMed
9 Saccani S et al. Modulation of NF-kappaB activity by exchange of dimers. Mol. Cell 2003 Jun;11(6):1563-74
Saccani S et al
2003/01/01
Applications: WB PubMed
10 Bernasconi D et al. The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells. J. Biol. Chem. 2005 Jun;280(25):24127-34
Bernasconi D et al
2005/01/01
Species: Human, Applications: WB PubMed
11 Strozyk E et al. Differential effects of NF-kappaB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome. Oncogene 2006 Oct;25(47):6239-51
Strozyk E et al
2006/01/01
Species: Human, Applications: WB PubMed
12 Napolitani G et al. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 2005 Aug;6(8):769-76
Napolitani G et al
2005/01/01
Species: Human, Applications: WB PubMed
13 Shakibaei M et al. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem. Pharmacol.
Shakibaei M et al
2007/01/01
Applications: PubMed
14 Ishiguro K et al. Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation. Toxicol. Appl. Pharmacol. 2006 Nov;217(1):35-42
Ishiguro K et al
2006/01/01
Species: Mouse, Applications: WB PubMed
15 Macagno A et al. A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. J. Exp. Med. 2006 Jun;203(6):1481-92
Macagno A et al
2006/01/01
Applications: WB PubMed
16 Xia YF et al. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J. Immunol. 2004 Sep;173(6):4207-17
Xia YF et al
2004/01/01
Applications: WB PubMed
17 Saccani S et al. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat. Immunol. 2002 Jan;3(1):69-75
Saccani S et al
2002/01/01
Species: Human, Applications: WB PubMed
18 Saccani S et al. Two waves of nuclear factor kappaB recruitment to target promoters. J. Exp. Med. 2001 Jun;193(12):1351-9
Saccani S et al
2001/01/01
Species: Mouse, Applications: WB PubMed
19 Yang XY et al. Inhibition of NADPH Oxidase Mediates Protective Effect of Cardiotonic Pills against Rat Heart Ischemia/Reperfusion Injury. Evid Based Complement Alternat Med 2013;2013:728020
Yang XY et al
2013/01/01
Species: Rat, Applications: IHC-P PubMed
20 Perez-Moreno M et al. p120-catenin mediates inflammatory responses in the skin. Cell 2006 Feb;124(3):631-44
Perez-Moreno M et al
2006/01/01
Species: Mouse, Applications: WB PubMed
21 Harikumar KB et al. Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathway. Mol. Pharmacol. 2010 May;77(5):818-27
Harikumar KB et al
2010/01/01
Applications: PubMed
22 Tabit CE et al. Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation 2013 Jan;127(1):86-95
Tabit CE et al
2013/01/01
Species: Human, Applications: ICC/IF PubMed
23 Santhi WS et al. NF-kappaB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins. Exp. Mol. Pathol. 2006 Oct;81(2):123-30
Santhi WS et al
2006/01/01
Applications: PubMed
24 Pejanovic N et al. Regulation of nuclear factor κB (NF-κB) transcriptional activity via p65 acetylation by the chaperonin containing TCP1 (CCT). PLoS ONE 2012;7(7):e42020
Pejanovic N et al
2012/01/01
Applications: PubMed
25 Delhase M et al. TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc. Natl. Acad. Sci. U.S.A. 2012 Jan;109(4):E177-86
Delhase M et al
2012/01/01
Applications: PubMed
26 Han HS et al. Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. J. Cereb. Blood Flow Metab. 2003 May;23(5):589-98
Han HS et al
2003/01/01
PubMed
  • No.: 1
  • 文献情報:
    Saccani S et al. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J. Exp. Med. 2004 Jul;200(1):107-13
    Saccani S et al
    2004/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Yang M et al. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J. Immunol. 2005 Sep;175(5):2814-24
    Yang M et al
    2005/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Goodkin ML et al. NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection. J. Virol. 2003 Jul;77(13):7261-80
    Goodkin ML et al
    2003/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Endo T et al. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 2007 Jan;109(2):703-10
    Endo T et al
    2007/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Ikezoe T et al. PC-SPES: a potent inhibitor of nuclear factor-kappa B rescues mice from lipopolysaccharide-induced septic shock. Mol. Pharmacol. 2003 Dec;64(6):1521-9
    Ikezoe T et al
    2003/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Vilimas T et al. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat. Med. 2007 Jan;13(1):70-7
    Vilimas T et al
    2007/01/01
  • 備考:
    Applications: WB, IP
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Nishioka C et al. DHMEQ, a novel nuclear factor-kappaB inhibitor, induces selective depletion of alloreactive or phytohaemagglutinin-stimulated peripheral blood mononuclear cells, decreases production of T helper type 1 cytokines, and blocks maturation of
    Nishioka C et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Chang L et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006 Feb;124(3):601-13
    Chang L et al
    2006/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Saccani S et al. Modulation of NF-kappaB activity by exchange of dimers. Mol. Cell 2003 Jun;11(6):1563-74
    Saccani S et al
    2003/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Bernasconi D et al. The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells. J. Biol. Chem. 2005 Jun;280(25):24127-34
    Bernasconi D et al
    2005/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Strozyk E et al. Differential effects of NF-kappaB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome. Oncogene 2006 Oct;25(47):6239-51
    Strozyk E et al
    2006/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Napolitani G et al. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 2005 Aug;6(8):769-76
    Napolitani G et al
    2005/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Shakibaei M et al. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem. Pharmacol.
    Shakibaei M et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Ishiguro K et al. Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation. Toxicol. Appl. Pharmacol. 2006 Nov;217(1):35-42
    Ishiguro K et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Macagno A et al. A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. J. Exp. Med. 2006 Jun;203(6):1481-92
    Macagno A et al
    2006/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Xia YF et al. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J. Immunol. 2004 Sep;173(6):4207-17
    Xia YF et al
    2004/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Saccani S et al. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat. Immunol. 2002 Jan;3(1):69-75
    Saccani S et al
    2002/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Saccani S et al. Two waves of nuclear factor kappaB recruitment to target promoters. J. Exp. Med. 2001 Jun;193(12):1351-9
    Saccani S et al
    2001/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Yang XY et al. Inhibition of NADPH Oxidase Mediates Protective Effect of Cardiotonic Pills against Rat Heart Ischemia/Reperfusion Injury. Evid Based Complement Alternat Med 2013;2013:728020
    Yang XY et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Perez-Moreno M et al. p120-catenin mediates inflammatory responses in the skin. Cell 2006 Feb;124(3):631-44
    Perez-Moreno M et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Harikumar KB et al. Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathway. Mol. Pharmacol. 2010 May;77(5):818-27
    Harikumar KB et al
    2010/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Tabit CE et al. Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation 2013 Jan;127(1):86-95
    Tabit CE et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Santhi WS et al. NF-kappaB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins. Exp. Mol. Pathol. 2006 Oct;81(2):123-30
    Santhi WS et al
    2006/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Pejanovic N et al. Regulation of nuclear factor κB (NF-κB) transcriptional activity via p65 acetylation by the chaperonin containing TCP1 (CCT). PLoS ONE 2012;7(7):e42020
    Pejanovic N et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Delhase M et al. TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc. Natl. Acad. Sci. U.S.A. 2012 Jan;109(4):E177-86
    Delhase M et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Han HS et al. Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. J. Cereb. Blood Flow Metab. 2003 May;23(5):589-98
    Han HS et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed